Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315702842> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4315702842 endingPage "e36" @default.
- W4315702842 startingPage "e36" @default.
- W4315702842 abstract "The renin-angiotensin-system (RAS) is one of the oldest known hormonal systems preserved in multiple species over millions of years. A key enzyme of the system, renin, was discovered in 1898, and ever since a huge body of research has continuously revealed physiological and pathophysiological features of the RAS. Classically, these include, via the so-called angiotensin AT1 receptor, powerful vasoconstriction, regulation of the body fluid balance by inducing thirst, stimulation of aldosterone release from the adrenal cortex, renal salt retention, stimulation of the sympathetic nervous system and, more recently discovered, pro-fibrotic and pro-inflammatory effects. Pathophysiological actions of the RAS, with its extension to those of aldosterone (RAAS), include the induction of arterial hypertension, cardiac and vascular hypertrophy, lung and renal fibrosis, vascular atherosclerosis, perivascular fibrosis or chronic inflammation and others. Attempts to inhibit the RAS in hypertension and other cardiovascular diseases first led to the clinical introduction of ACE-inhibitors some forty years ago, followed by selective antagonists of the AT1 receptor, the sartans. After a multitude of evidence-generating trials and global success in clinical practice, both approaches are now firmly established in the therapy of hypertension as well as cardio-metabolic and renal diseases. More recently, research has focused on the so-called protective arm of the RAS, mediated by stimulation of the angiotensin AT2 receptor by or by the Mas receptor stimulated by the angiotensin 1–7 peptide. Activation of these systems has exhibited beneficial effects in numerous preclinical studies via opposing AT1-mediated actions and beyond. Other degradation peptides of the angiotensin precursor, angiotensinogen, may also exhibit protective effects via these receptors. Agonists for the AT2 receptor as well as for the ACE2-Mas system have been developed and are currently under clinical evaluation. It remains to be seen whether the pharmacological stimulation of the protective arm of the RAS will become an effective clinical tool in various cardiovascular and metabolic indications. Theoretically, it would make sense not only to block the harmful RAS but, at the same time, also stimulate the beneficial actions of the system." @default.
- W4315702842 created "2023-01-12" @default.
- W4315702842 creator A5052836637 @default.
- W4315702842 date "2023-01-01" @default.
- W4315702842 modified "2023-10-02" @default.
- W4315702842 title "S-12-7: THE RENIN ANGIOTENSIN SYSTEM IN BASIC AND CLINICAL RESEARCH" @default.
- W4315702842 doi "https://doi.org/10.1097/01.hjh.0000913052.28654.d3" @default.
- W4315702842 hasPublicationYear "2023" @default.
- W4315702842 type Work @default.
- W4315702842 citedByCount "0" @default.
- W4315702842 crossrefType "journal-article" @default.
- W4315702842 hasAuthorship W4315702842A5052836637 @default.
- W4315702842 hasBestOaLocation W43157028421 @default.
- W4315702842 hasConcept C104849204 @default.
- W4315702842 hasConcept C123915805 @default.
- W4315702842 hasConcept C126322002 @default.
- W4315702842 hasConcept C134018914 @default.
- W4315702842 hasConcept C170493617 @default.
- W4315702842 hasConcept C198710026 @default.
- W4315702842 hasConcept C2778525890 @default.
- W4315702842 hasConcept C2779961880 @default.
- W4315702842 hasConcept C2780091579 @default.
- W4315702842 hasConcept C2780559512 @default.
- W4315702842 hasConcept C2908929049 @default.
- W4315702842 hasConcept C57190642 @default.
- W4315702842 hasConcept C71924100 @default.
- W4315702842 hasConcept C84393581 @default.
- W4315702842 hasConcept C98274493 @default.
- W4315702842 hasConceptScore W4315702842C104849204 @default.
- W4315702842 hasConceptScore W4315702842C123915805 @default.
- W4315702842 hasConceptScore W4315702842C126322002 @default.
- W4315702842 hasConceptScore W4315702842C134018914 @default.
- W4315702842 hasConceptScore W4315702842C170493617 @default.
- W4315702842 hasConceptScore W4315702842C198710026 @default.
- W4315702842 hasConceptScore W4315702842C2778525890 @default.
- W4315702842 hasConceptScore W4315702842C2779961880 @default.
- W4315702842 hasConceptScore W4315702842C2780091579 @default.
- W4315702842 hasConceptScore W4315702842C2780559512 @default.
- W4315702842 hasConceptScore W4315702842C2908929049 @default.
- W4315702842 hasConceptScore W4315702842C57190642 @default.
- W4315702842 hasConceptScore W4315702842C71924100 @default.
- W4315702842 hasConceptScore W4315702842C84393581 @default.
- W4315702842 hasConceptScore W4315702842C98274493 @default.
- W4315702842 hasIssue "Suppl 1" @default.
- W4315702842 hasLocation W43157028421 @default.
- W4315702842 hasLocation W43157028422 @default.
- W4315702842 hasOpenAccess W4315702842 @default.
- W4315702842 hasPrimaryLocation W43157028421 @default.
- W4315702842 hasRelatedWork W1974641745 @default.
- W4315702842 hasRelatedWork W2016647631 @default.
- W4315702842 hasRelatedWork W2024736606 @default.
- W4315702842 hasRelatedWork W2026362575 @default.
- W4315702842 hasRelatedWork W2026625444 @default.
- W4315702842 hasRelatedWork W2069444929 @default.
- W4315702842 hasRelatedWork W2126797993 @default.
- W4315702842 hasRelatedWork W2151139437 @default.
- W4315702842 hasRelatedWork W4247631657 @default.
- W4315702842 hasRelatedWork W74001706 @default.
- W4315702842 hasVolume "41" @default.
- W4315702842 isParatext "false" @default.
- W4315702842 isRetracted "false" @default.
- W4315702842 workType "article" @default.